Generic drug markets will commoditise gradually through policies such as internal reference pricing, generic prescribing, generic substitution, and tendering. The introduction and enforcement of these guidelines will vary between countries, and are influenced by a variety of economic, political and cultural issues. Multinational manufacturers of generic drugs will therefore have to develop and employ a variety of market access strategies and operational campaigns.

Global

Africa

Europe

Latin America

Middle East

North America